A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
Status:
Completed
Trial end date:
2019-05-17
Target enrollment:
Participant gender:
Summary
A phase 2,double-blinded, double dummy, parallel, positive drug, randomised controlled
multicenter trial to evaluate efficacy and safety of 4 weeks treatment of Anaprazole 20mg QD,
40mg QD compared with rabeprazole 10mg QD in patients with duodenal ulcers.